The stent grafts market size has the potential to grow by $ 838.38 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.

This report provides a detailed analysis of the market by product (coronary stent grafts, and peripheral stent grafts), and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Becton, Dickinson and Co., Cardinal Health Inc., Cook Group Inc., CryoLife Inc., Endologix Inc., Endospan Ltd., Medtronic Plc, MicroPort Scientific Corp., Terumo Corp., and W. L. Gore & Associates Inc.

Market Overview

Market Competitive Analysis

The market is fragmented, and the degree of fragmentation will decrease during the forecast period. Vendors are engaging in M&A activities as a business strategy to expand their portfolio and strengthen their business. Endospan Ltd., Medtronic Plc, MicroPort Scientific Corp., Terumo Corp., and W. L. Gore & Associates Inc. are some of the major market participants. Although the increasing prevalence of aortic aneurysms and co-morbidities will offer immense growth opportunities, stringent regulation and complications associated with stent graft procedures will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this stent grafts market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this stent grafts market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading companies, including:

• Becton, Dickinson and Co.
• Cardinal Health Inc.
• Cook Group Inc.
• CryoLife Inc.
• Endologix Inc.
• Endospan Ltd.
• Medtronic Plc
• MicroPort Scientific Corp.
• Terumo Corp.
• W. L. Gore & Associates Inc.

Stent Grafts Market: Segmentation by Region

North America had the largest stent grafts market share in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The rising prevalence of vascular diseases, growing demand for minimally invasive endovascular surgeries, and presence of prominent medical device manufacturers will significantly influence stent grafts market growth in this region.

37% of the market’s growth will originate from North America during the forecast period. The US is the key market for stent grafts in North America. Market growth in this region will be slower than the growth of the market in Europe and Asia.

Stent Grafts Market: Segmentation by Product

The increasing prevalence of AAAs and TAAs, increasing product launches, technological advances, coupled with favorable reimbursement policies for coronary heart disease treatment. Moreover, the growing preference for minimally invasive endovascular aortic repair over open surgeries will also propel the growth of the coronary application segment.

Market growth in this segment will be slower than the growth of the market in the peripheral stent grafts segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the stent grafts market size.

Stent Grafts Market: Key Drivers and Trends

The rising preference for MI EVAR to treat aortic aneurysms will be a significant factor driving the growth of the aortic stent grafts market. The preference for EVAR over traditional open surgeries is growing for the treatment of both AAA and TAA because of its lower mortality and lesser risk of complications and blood transfusion. EVAR is an MI procedure which involves smaller incisions and can be performed under local anesthesia. Moreover, it is convenient and comfortable for patients and requires a shorter duration of hospital stay post-EVAR procedures. Stent grafts are used in transcatheter EVAR procedures to seal aortic aneurysms. Hence, with the expansion of indication for the treatment of anatomically complicated pararenal and suprarenal AAA, the preference for EVAR, and consequently, the demand for aortic stent grafts will also grow.

• Major abdominal surgeries for the treatment of patients with aneurysms near the renal arteries are complex and require proper graft placement.
• Technological advances have enabled the development of solutions such as Fenestrated Endograft (FEVAR) that offer various benefits, including short hospital stay, quick recovery, and lesser complications than open surgeries.
• To overcome the challenges of migration and endoleaks in existing stent graft technologies, market vendors are researching the viability of filling the aneurysm sac with a polymer in addition to stenting.
• Technological advances and the introduction of technologically advanced products, which are critical aortic stent grafts market trends, will reduce the need for traditional surgical procedures and minimize several risks.
• During 2020-2024, the aortic stent grafts market will grow at a CAGR of over

Stent Grafts Market: Key Highlights of the Report for the Forecast Period 2020-2024

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will drive stent grafts market growth during the next five years
• Precise estimation of the stent grafts market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the stent grafts market industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of stent grafts market vendors